FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073001884> ?p ?o ?g. }

• W2073001884 abstract "We evaluated the safety and efficacy of the purine nucleoside analogue, clofarabine, in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL). Six patients with DLBCL (n = 5) or MCL (n = 1) and a median age of 68 years were treated with 40 mg/m(2) clofarabine IV over 2 h for 5 days, repeated every 28 days, for 1-2 cycles. The overall response rate was 50% (complete response = 1, complete response unconfirmed = 1, partial response = 1). Median progression-free survival was 3.5 months (range 1.5-10 months) and the median overall survival was 7.8 months (range 3-31 months). Grade 3-4 neutropenia and thrombocytopenia was universal, with a median of 34 (range 19-55) and 77 (range 0-275) days required for neutrophil and platelet recovery. Grade 3 non-hematologic toxicities included transaminitis, febrile neutropenia, non-neutropenic infections and orthostatic hypotension. Further accrual to the study was terminated due to prolonged Grade 3-4 myelosuppression and orthostatic hypotension in five of six patients. Clofarabine exhibits evidence of single agent activity in relapsed or refractory DLBCL. However, further study with novel administration schedules that maintain this efficacy and limit toxicity is warranted." @default.
• W2073001884 created "2016-06-24" @default.
• W2073001884 creator A5000921376 @default.
• W2073001884 creator A5007847102 @default.
• W2073001884 creator A5011030256 @default.
• W2073001884 creator A5012846289 @default.
• W2073001884 creator A5018821266 @default.
• W2073001884 creator A5021564306 @default.
• W2073001884 creator A5038703170 @default.
• W2073001884 creator A5041950455 @default.
• W2073001884 creator A5055443268 @default.
• W2073001884 creator A5056451559 @default.
• W2073001884 creator A5056946123 @default.
• W2073001884 creator A5091600784 @default.
• W2073001884 date "2009-01-01" @default.
• W2073001884 modified "2023-09-24" @default.
• W2073001884 title "Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma" @default.
• W2073001884 cites W137167786 @default.
• W2073001884 cites W1785340630 @default.
• W2073001884 cites W1848698181 @default.
• W2073001884 cites W1881397173 @default.
• W2073001884 cites W1912693401 @default.
• W2073001884 cites W1935154669 @default.
• W2073001884 cites W1963418965 @default.
• W2073001884 cites W2029409133 @default.
• W2073001884 cites W2035766348 @default.
• W2073001884 cites W2058015212 @default.
• W2073001884 cites W2095520712 @default.
• W2073001884 cites W2099249352 @default.
• W2073001884 cites W2102776788 @default.
• W2073001884 cites W2103563361 @default.
• W2073001884 cites W2116171965 @default.
• W2073001884 cites W2117291755 @default.
• W2073001884 cites W2117964879 @default.
• W2073001884 cites W2119267046 @default.
• W2073001884 cites W2131637500 @default.
• W2073001884 cites W2140291353 @default.
• W2073001884 cites W2142867377 @default.
• W2073001884 cites W2152229600 @default.
• W2073001884 cites W2157514847 @default.
• W2073001884 cites W2160881482 @default.
• W2073001884 cites W2163334163 @default.
• W2073001884 cites W2166989515 @default.
• W2073001884 cites W2167571754 @default.
• W2073001884 cites W2202391029 @default.
• W2073001884 cites W2254608986 @default.
• W2073001884 cites W2318772898 @default.
• W2073001884 cites W2524411156 @default.
• W2073001884 cites W2591320081 @default.
• W2073001884 doi "https://doi.org/10.1080/10428190902730227" @default.
• W2073001884 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3695225" @default.
• W2073001884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19263294" @default.
• W2073001884 hasPublicationYear "2009" @default.
• W2073001884 type Work @default.
• W2073001884 sameAs 2073001884 @default.
• W2073001884 citedByCount "10" @default.
• W2073001884 countsByYear W20730018842013 @default.
• W2073001884 countsByYear W20730018842014 @default.
• W2073001884 countsByYear W20730018842017 @default.
• W2073001884 crossrefType "journal-article" @default.
• W2073001884 hasAuthorship W2073001884A5000921376 @default.
• W2073001884 hasAuthorship W2073001884A5007847102 @default.
• W2073001884 hasAuthorship W2073001884A5011030256 @default.
• W2073001884 hasAuthorship W2073001884A5012846289 @default.
• W2073001884 hasAuthorship W2073001884A5018821266 @default.
• W2073001884 hasAuthorship W2073001884A5021564306 @default.
• W2073001884 hasAuthorship W2073001884A5038703170 @default.
• W2073001884 hasAuthorship W2073001884A5041950455 @default.
• W2073001884 hasAuthorship W2073001884A5055443268 @default.
• W2073001884 hasAuthorship W2073001884A5056451559 @default.
• W2073001884 hasAuthorship W2073001884A5056946123 @default.
• W2073001884 hasAuthorship W2073001884A5091600784 @default.
• W2073001884 hasBestOaLocation W20730018842 @default.
• W2073001884 hasConcept C121332964 @default.
• W2073001884 hasConcept C126322002 @default.
• W2073001884 hasConcept C141071460 @default.
• W2073001884 hasConcept C142424586 @default.
• W2073001884 hasConcept C2776694085 @default.
• W2073001884 hasConcept C2777063308 @default.
• W2073001884 hasConcept C2777198975 @default.
• W2073001884 hasConcept C2777525834 @default.
• W2073001884 hasConcept C2778041864 @default.
• W2073001884 hasConcept C2778850193 @default.
• W2073001884 hasConcept C2779338263 @default.
• W2073001884 hasConcept C29730261 @default.
• W2073001884 hasConcept C71924100 @default.
• W2073001884 hasConcept C74133956 @default.
• W2073001884 hasConcept C87355193 @default.
• W2073001884 hasConcept C90924648 @default.
• W2073001884 hasConceptScore W2073001884C121332964 @default.
• W2073001884 hasConceptScore W2073001884C126322002 @default.
• W2073001884 hasConceptScore W2073001884C141071460 @default.
• W2073001884 hasConceptScore W2073001884C142424586 @default.
• W2073001884 hasConceptScore W2073001884C2776694085 @default.
• W2073001884 hasConceptScore W2073001884C2777063308 @default.
• W2073001884 hasConceptScore W2073001884C2777198975 @default.
• W2073001884 hasConceptScore W2073001884C2777525834 @default.
• W2073001884 hasConceptScore W2073001884C2778041864 @default.
• W2073001884 hasConceptScore W2073001884C2778850193 @default.
• W2073001884 hasConceptScore W2073001884C2779338263 @default.

• next